Biograil ApS announced that it has received a round of funding on April 5, 2024. The transaction included participation from new investors, Roquette Ventures, Eli Lilly and Company, returning investors, High-Tech Gründerfonds Management GmbH, Megatrend Invest A/S, Sanner Ventures GmbH, Verve Capital Partners AG, and Evonik Venture Capital GmbH.